Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 400
interventional 379
Observational 20
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 213
Drug|placebo 63
Device 30
Drug|Other 17
Other 17
Device|Drug 7
Procedure 7
Behavioral 4
Other|placebo 4
Drug|Procedure 3
Behavioral|Drug 2
Biological 2
Device|Procedure 2
Biological|Other 1
Biological|placebo 1
Combination Product|Drug 1
Combination Product|Drug|Other 1
Device|placebo 1
Dietary Supplement|placebo 1
Drug|Other|Radiation 1
Drug|placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 190
NA 35
United States|Canada 20
China 11
Canada 9
Japan 9
Thailand 7
United States|Belize 7
Germany 6
India 6
Korea, Republic of 6
Israel 5
Denmark 4
Egypt 4
Australia 3
Brazil 3
United States|Australia|Canada 3
United States|Belize|Canada 3
Canada|France 2
France 2
Poland 2
Spain 2
United Kingdom 2
United States|Canada|Puerto Rico 2
United States|Dominican Republic 2
Argentina 1
Australia|Belgium|Brazil|France|Germany|Italy|Mexico|Poland|Sweden 1
Australia|New Zealand 1
Austria 1
Belgium 1
Belgium|Netherlands 1
Canada|France|Germany 1
Chile 1
Colombia 1
Czech Republic|Poland|Russian Federation|Slovakia|Ukraine 1
Denmark|Switzerland 1
Dominican Republic 1
Dominican Republic|Honduras|Panama 1
Greece 1
Indonesia 1
Iran, Islamic Republic of 1
Mexico 1
Netherlands 1
Philippines 1
Poland|United Kingdom 1
United States|Australia 1
United States|Belize|India 1
United States|Bulgaria|Georgia|Poland|Romania|Serbia 1
United States|Bulgaria|Georgia|Poland|Romania|Serbia|Ukraine 1
United States|Canada|Germany|Hungary|Poland 1
United States|Canada|Germany|Hungary|Puerto Rico 1
United States|Czechia|Germany|Hungary 1
United States|Czechia|Germany|Hungary|Netherlands 1
United States|Czechia|Hungary|Poland|Romania|Russian Federation|Spain|Ukraine 1
United States|Georgia|Ukraine 1
United States|India 1
United States|Mauritius|Singapore 1
United States|Poland 1
United States|Taiwan 1

Sites per Study

Site_count Study_Count
1 205
2 23
3 18
4 5
5 2
6 3
7 5
8 1
9 5
10 6
11 3
12 6
13 5
14 2
15 7
16 4
17 2
18 2
19 3
20 7
21 1
22 3
23 1
24 5
25 5
26 2
27 1
28 1
29 2
30 1
31 3
32 2
33 2
34 8
35 2
36 4
38 1
39 1
45 1
46 1
49 2
50 1
52 1
54 1
55 2
56 1
57 2
62 2
69 1
74 1
81 1
94 1
98 1
124 1

Phase

Phase Study_Count
Phase 3 89
Phase 4 75
N/A 71
Phase 2 69
Phase 1 53
Phase 1/Phase 2 15
Phase 2/Phase 3 5
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 69
2 170
3 74
4 30
5 10
6 3
9 3
NA 20

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 455.00 4.0000 8.0000 30.00000 11.0000 25.0 30.0000 12.00000
1st Qu. 516.25 20.0000 30.0000 35.50000 50.0000 50.0 434.0000 28.00000
Median 577.50 45.0000 54.0000 70.00000 150.0000 66.0 744.0000 60.00000
Mean 577.50 128.4058 273.9811 94.73333 197.1304 136.4 785.5506 88.34667
3rd Qu. 638.75 98.0000 254.0000 139.50000 294.0000 169.0 1110.0000 126.00000
Max. 700.00 1225.0000 2008.0000 245.00000 741.0000 372.0 2361.0000 382.00000

Trial Group Type

group_type Group_Count
Experimental 411
Active Comparator 218
Placebo Comparator 182
NA 20
Other 16
No Intervention 10
Sham Comparator 9

Intervention Model

intervention_model Study_Count
Parallel Assignment 269
Single Group Assignment 98
Crossover Assignment 6
Factorial Assignment 4
Sequential Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 345
Basic Science 12
NA 8
Other 7
Health Services Research 4
Prevention 2
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
United States 10
NA 3
Austria|Czech Republic|France|Netherlands|Spain 1
Canada 1
Egypt 1
France|Italy|Poland 1
Indonesia 1
Italy|Netherlands|United Kingdom 1
Turkey 1

Sites per Study

Site_count Study_Count
1 14
2 1
3 1
5 1
6 1
8 1
16 1

Enrollment Metrics

Measure Observational
Min 15.00
1st Qu 64.50
Median 120.00
Mean 1944.80
3rd Qu 414.75
Max 26065.00

Observation Model

observational_model Study_Count
Cohort 10
Case-Only 3
Other 3
Case-Control 2
Case Control 1
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 9
Cross-Sectional 4
Other 3
Retrospective 3
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
Italy 1

Sites per Study

Site_count Study_Count
1 1

Enrollment Metrics

Measure Registries
Min 40
1st Qu 40
Median 40
Mean 40
3rd Qu 40
Max 40

Registry Model

observational_model Study_Count
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 1

Follow-up

target_duration Study_Count
2 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04461366 Monopolar Radiofrequency Versus Pulsed Dye Laser for Treatment of Acne Scars https://ClinicalTrials.gov/show/NCT04461366 Completed Cairo University 2019-12-30
NCT02058628 Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02058628 Completed GlaxoSmithKline 2014-09-08
NCT03393494 Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face https://ClinicalTrials.gov/show/NCT03393494 Completed Perrigo Company 2018-09-30
NCT03380845 Comparison of 1,550-nm Laser and Fractional Radiofrequency Microneedle for the Treatment of Acne Scars in Ethnic Skin https://ClinicalTrials.gov/show/NCT03380845 Completed Massachusetts General Hospital 2018-10-30
NCT03361345 Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris https://ClinicalTrials.gov/show/NCT03361345 Recruiting Wayne State University 2021-12-31
NCT03341910 A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® (Tazarotene) Cream, 0.1% in the Topical Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03341910 Completed Dr. Reddy’s Laboratories Limited 2018-05-18
NCT03334682 Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. https://ClinicalTrials.gov/show/NCT03334682 Recruiting Nantes University Hospital 2021-12-31
NCT03303170 Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT03303170 Completed Sebacia, Inc. 2018-04-10
NCT03290027 A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03290027 Completed Dr. Reddy’s Laboratories Limited 2018-04-19
NCT03264287 Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT03264287 Recruiting Guang’anmen Hospital of China Academy of Chinese Medical Sciences 2019-12-31
NCT03178994 The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne https://ClinicalTrials.gov/show/NCT03178994 Completed Chulalongkorn University 2018-09-15
NCT03170388 A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03170388 Completed Bausch Health Americas, Inc. 2019-04-23
NCT03168334 Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03168334 Completed Bausch Health Americas, Inc. 2018-04-26
NCT03168321 A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03168321 Completed Bausch Health Americas, Inc. 2018-03-16
NCT03128723 A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT03128723 Completed Johnson & Johnson Consumer and Personal Products Worldwide 2017-06-08
NCT03127956 A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT03127956 Completed Dermira, Inc. 2018-04-27
NCT03124381 A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne https://ClinicalTrials.gov/show/NCT03124381 Completed Johnson & Johnson Consumer and Personal Products Worldwide 2017-09-06
NCT03073486 A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT03073486 Completed Dermira, Inc. 2017-12-21
NCT03057821 Propionibacterium Acnes in Shoulder Arthroplasty https://ClinicalTrials.gov/show/NCT03057821 Completed University of Utah 2019-03-31
NCT03034460 Efficacy and Safety of CD5024 1% in Acne Vulgaris https://ClinicalTrials.gov/show/NCT03034460 Completed Galderma R&D 2016-11-30
NCT03028363 A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT03028363 Completed Dermira, Inc. 2017-11-28
NCT03003247 Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03003247 Completed Bausch Health Americas, Inc. 2016-08-31
NCT02965456 Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02965456 Completed Bausch Health Americas, Inc. 2017-02-23
NCT02959970 Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02959970 Completed Almirall, S.A. 2018-03-09
NCT02946788 Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel https://ClinicalTrials.gov/show/NCT02946788 Completed BioPharmX, Inc. 2018-06-01
NCT02944461 Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris https://ClinicalTrials.gov/show/NCT02944461 Completed Derm Research, PLLC 2017-09-30
NCT02938494 Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02938494 Completed Bausch Health Americas, Inc. 2016-07-31
NCT02935036 Efficacy Study in Patients With Acne Vulgaris. https://ClinicalTrials.gov/show/NCT02935036 Completed Taro Pharmaceuticals USA 2017-01-24
NCT02932306 Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02932306 Completed Bausch Health Americas, Inc. 2017-02-22
NCT02932267 Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne https://ClinicalTrials.gov/show/NCT02932267 Completed Galderma 2018-01-10
NCT02929719 Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02929719 Completed Taro Pharmaceuticals USA 2016-06-30
NCT02913001 The Effect of a Low Glycemic Load Diet on Hormonal Markers Associated With Acne https://ClinicalTrials.gov/show/NCT02913001 Completed New York University 2015-11-30
NCT02905851 Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris https://ClinicalTrials.gov/show/NCT02905851 Completed University of California, Davis 2018-05-31
NCT02899000 A Treatment for Severe Inflammatory Acne Subjects https://ClinicalTrials.gov/show/NCT02899000 Completed Galderma Laboratories, L.P. 2017-03-28
NCT02886715 A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02886715 Completed Fougera Pharmaceuticals Inc. 2017-05-31
NCT02865005 Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02865005 Completed Seegpharm S.A. 2016-11-30
NCT02849860 Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02849860 Completed Bausch Health Americas, Inc. 2016-09-30
NCT02832063 Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT02832063 Completed AOBiome LLC 2017-07-19
NCT02815332 BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02815332 Completed BioPharmX, Inc. 2017-03-24
NCT02815280 A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne https://ClinicalTrials.gov/show/NCT02815280 Completed Foamix Ltd. 2017-10-13
NCT02815267 A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne https://ClinicalTrials.gov/show/NCT02815267 Completed Foamix Ltd. 2017-10-13
NCT02801903 Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02801903 Completed Novan, Inc. 2016-08-31
NCT02798120 P3 Long Term Safety Study of Once Daily SB204 in Acne https://ClinicalTrials.gov/show/NCT02798120 Completed Novan, Inc. 2017-04-30
NCT02774590 Timolol for the Treatment of Acne and Rosacea https://ClinicalTrials.gov/show/NCT02774590 Recruiting Johns Hopkins University 2025-03-31
NCT02758041 A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris https://ClinicalTrials.gov/show/NCT02758041 Completed Sebacia, Inc. 2017-01-31
NCT02755545 A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments https://ClinicalTrials.gov/show/NCT02755545 Completed Galderma Laboratories, L.P. 2017-04-04
NCT02735421 Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars https://ClinicalTrials.gov/show/NCT02735421 Completed Galderma 2017-06-05
NCT02731105 Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products https://ClinicalTrials.gov/show/NCT02731105 Completed GWT-TUD GmbH 2017-02-21
NCT02721173 Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT02721173 Completed All India Institute of Medical Sciences, Bhubaneswar 2016-12-31
NCT02720627 An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02720627 Completed Cassiopea SpA 2018-03-21
NCT02713607 Lipidome and Microbiome Profile of Acne https://ClinicalTrials.gov/show/NCT02713607 Active, not recruiting University of California, Davis 2027-01-31
NCT02709902 Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02709902 Completed Taro Pharmaceuticals USA 2016-02-29
NCT02709096 BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes https://ClinicalTrials.gov/show/NCT02709096 Completed BioPharmX, Inc. 2016-06-30
NCT02698436 A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. https://ClinicalTrials.gov/show/NCT02698436 Completed Johnson & Johnson Consumer and Personal Products Worldwide 2016-08-31
NCT02682264 An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02682264 Completed Cassiopea SpA 2018-08-31
NCT02672332 P3 Study in Acne Comparing Once Daily SB204 and Vehicle https://ClinicalTrials.gov/show/NCT02672332 Completed Novan, Inc. 2016-12-31
NCT02667444 P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne https://ClinicalTrials.gov/show/NCT02667444 Completed Novan, Inc. 2016-12-31
NCT02661958 Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02661958 Completed Sol-Gel Technologies, Ltd. 2017-10-31
NCT02656485 A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02656485 Completed AOBiome LLC 2016-03-01
NCT02656043 A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel https://ClinicalTrials.gov/show/NCT02656043 Completed Xenon Pharmaceuticals Inc. 2017-02-16
NCT02646917 SkinPen Efficacy on Acne Scars on the Face and/or Back https://ClinicalTrials.gov/show/NCT02646917 Completed Bellus Medical, LLC 2016-12-31
NCT02643628 A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars https://ClinicalTrials.gov/show/NCT02643628 Completed Suneva Medical, Inc. 2017-06-05
NCT02620813 De Novo Lipogenesis of Sebaceous Glands in Acne https://ClinicalTrials.gov/show/NCT02620813 Completed University of California, Davis 2017-10-12
NCT02616614 Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris https://ClinicalTrials.gov/show/NCT02616614 Completed Actavis Inc. 2015-10-31
NCT02608476 A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) https://ClinicalTrials.gov/show/NCT02608476 Completed Cassiopea SpA 2018-02-21
NCT02608450 A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) https://ClinicalTrials.gov/show/NCT02608450 Completed Cassiopea SpA 2018-04-11
NCT02604680 A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT02604680 Completed Braintree Laboratories 2016-06-30
NCT02595034 A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02595034 Completed Taro Pharmaceuticals USA 2015-10-31
NCT02593383 Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne https://ClinicalTrials.gov/show/NCT02593383 Completed Lee’s Pharmaceutical Limited 2017-07-31
NCT02589405 Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris https://ClinicalTrials.gov/show/NCT02589405 Completed Galderma 2016-01-31
NCT02578043 A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onextonâ„¢ Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02578043 Completed Taro Pharmaceuticals USA 2015-08-31
NCT02575950 Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne https://ClinicalTrials.gov/show/NCT02575950 Completed LEO Pharma 2017-04-30
NCT02571998 A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT02571998 Completed Maruho Co., Ltd. 2016-08-31
NCT03402893 The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color https://ClinicalTrials.gov/show/NCT03402893 Completed Derm Research, PLLC 2017-11-15
NCT02566369 Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris https://ClinicalTrials.gov/show/NCT02566369 Completed Galderma R&D 2017-11-14
NCT02557399 DUAC® Early Onset Efficacy Study in Japanese Subjects https://ClinicalTrials.gov/show/NCT02557399 Completed GlaxoSmithKline 2015-12-17
NCT00835198 Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT00835198 Completed Allergan 2009-08-31
NCT02524665 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne https://ClinicalTrials.gov/show/NCT02524665 Completed GlaxoSmithKline 2009-12-31
NCT02502669 Finasteride Treatment of Severe Nodulocystic Acne https://ClinicalTrials.gov/show/NCT02502669 Completed Elorac, Inc. 2017-06-06
NCT02498288 A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition https://ClinicalTrials.gov/show/NCT02498288 Completed GlaxoSmithKline 2013-07-15
NCT02465632 To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. https://ClinicalTrials.gov/show/NCT02465632 Completed Glenmark Pharmaceuticals Ltd. India 2015-11-30
NCT02457520 ABSORICA in Patients With Severe Recalcitrant Nodular Acne https://ClinicalTrials.gov/show/NCT02457520 Completed Sun Pharmaceutical Industries Limited 2018-04-30
NCT02431052 A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02431052 Completed Dermira, Inc. 2016-04-30
NCT02411955 A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02411955 Completed Taro Pharmaceuticals USA 2015-01-31
NCT02411942 Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02411942 Completed Taro Pharmaceuticals USA 2015-02-28
NCT02404285 A Study to Evaluate the Clinical Effect of Daily Next Scienceâ„¢ Acne Gel (NAG) on Mild to Moderate Facial Acne https://ClinicalTrials.gov/show/NCT02404285 Completed Next Science TM 2015-09-30
NCT02385760 CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT02385760 Completed Celtaxsys, Inc. 2016-05-31
NCT02322866 Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne https://ClinicalTrials.gov/show/NCT02322866 Completed Almirall, S.A. 2017-01-12
NCT02320149 Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne https://ClinicalTrials.gov/show/NCT02320149 Completed Almirall, S.A. 2017-02-01
NCT02313467 Topical PDT Cream Without Irradiation Source in the Acne Treatment https://ClinicalTrials.gov/show/NCT02313467 Completed Seoul National University Hospital 2015-02-28
NCT02307266 Patient Education in Adherence on Acne (PEAce) https://ClinicalTrials.gov/show/NCT02307266 Completed Galderma 2015-06-30
NCT02293018 Pharmacokinetic Study of MTC896 Gel in Subjects With Acne https://ClinicalTrials.gov/show/NCT02293018 Completed Mimetica Pty Limited 2015-01-31
NCT02267746 A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02267746 Completed Actavis Inc. 2014-09-30
NCT02250430 A Phase 1 Study Assessing Local Cutaneous Effects of SB204 https://ClinicalTrials.gov/show/NCT02250430 Completed Novan, Inc. 2014-09-30
NCT02249104 A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT02249104 Completed Galderma Laboratories, L.P. 2015-02-28
NCT02242760 P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02242760 Completed Novan, Inc. 2015-06-30
NCT02219074 Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02219074 Completed Sebacia, Inc. 2016-10-31
NCT02218034 Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT02218034 Completed Allergan 2015-03-31
NCT02217228 Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02217228 Completed Sebacia, Inc. 2015-12-31
NCT02207738 Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar https://ClinicalTrials.gov/show/NCT02207738 Completed Seoul National University Hospital 2013-05-31
NCT02205892 Clinical Study for Topical Lupeol in Acne https://ClinicalTrials.gov/show/NCT02205892 Completed Seoul National University Hospital 2014-09-30
NCT02189629 CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris https://ClinicalTrials.gov/show/NCT02189629 Completed Galderma R&D 2017-02-23
NCT02173054 An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne https://ClinicalTrials.gov/show/NCT02173054 Completed Mahidol University 2015-02-28
NCT02164084 A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris https://ClinicalTrials.gov/show/NCT02164084 Completed Novan, Inc. 2014-06-30
NCT02160678 Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02160678 Completed G & W Laboratories Inc. 2015-07-31
NCT02145364 Ultherapy® for the Treatment of Acne Scars https://ClinicalTrials.gov/show/NCT02145364 Completed Merz North America, Inc. 2015-07-31
NCT02103127 Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars https://ClinicalTrials.gov/show/NCT02103127 Completed Cynosure, Inc. 2015-05-31
NCT02103816 The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars https://ClinicalTrials.gov/show/NCT02103816 Completed Cynosure, Inc. 2015-02-28
NCT02073461 Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. https://ClinicalTrials.gov/show/NCT02073461 Completed Galderma R&D 2014-10-31
NCT02073448 Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. https://ClinicalTrials.gov/show/NCT02073448 Completed Galderma R&D 2014-10-31
NCT02066545 Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris https://ClinicalTrials.gov/show/NCT02066545 Completed Maruho Co., Ltd. 2014-11-30
NCT01313728 A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products https://ClinicalTrials.gov/show/NCT01313728 Completed Bausch Health Americas, Inc. 2010-12-31
NCT01293552 Clinical Trial To Evaluate ANT-1207 In Subjects With Acne https://ClinicalTrials.gov/show/NCT01293552 Completed Anterios Inc. 2012-04-30
NCT01289574 Topical ASC-J9 Cream for Acne https://ClinicalTrials.gov/show/NCT01289574 Completed AndroScience Corp 2012-07-31
NCT02032407 A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris https://ClinicalTrials.gov/show/NCT02032407 Completed Allergan 2014-06-30
NCT02031718 Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone https://ClinicalTrials.gov/show/NCT02031718 Completed University of California, Davis 2014-07-31
NCT02005666 To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel https://ClinicalTrials.gov/show/NCT02005666 Completed Cadila Healthcare Limited 2016-09-28
NCT01984801 Study to Investigate the Irritation Potential of GSK1940029 Gel https://ClinicalTrials.gov/show/NCT01984801 Completed GlaxoSmithKline 2015-04-10
NCT01974141 A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01974141 Completed Almirall, S.A. 2014-10-31
NCT01951417 Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT01951417 Completed Galderma Laboratories, L.P. 2014-03-31
NCT01938482 Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 https://ClinicalTrials.gov/show/NCT01938482 Completed GlaxoSmithKline 2015-02-17
NCT01936324 A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel https://ClinicalTrials.gov/show/NCT01936324 Completed Dermira, Inc. 2014-06-30
NCT01930565 Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study https://ClinicalTrials.gov/show/NCT01930565 Completed Seoul National University Hospital 2013-07-31
NCT01929278 W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers https://ClinicalTrials.gov/show/NCT01929278 Completed GlaxoSmithKline 2008-12-19
NCT01915758 W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01915758 Completed GlaxoSmithKline 2009-02-20
NCT01915732 A Efficacy and Safety of Duacâ„¢Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT01915732 Completed GlaxoSmithKline 2014-04-30
NCT01909713 Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. https://ClinicalTrials.gov/show/NCT01909713 Completed Galderma Laboratories, L.P. 2013-06-30
NCT01885910 Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel https://ClinicalTrials.gov/show/NCT01885910 Completed Derm Research, PLLC 2014-07-31
NCT01880320 Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris https://ClinicalTrials.gov/show/NCT01880320 Completed Galderma R&D 2014-03-31
NCT01844752 A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne https://ClinicalTrials.gov/show/NCT01844752 Completed Novan, Inc. 2013-11-30
NCT01844739 A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel https://ClinicalTrials.gov/show/NCT01844739 Completed Novan, Inc. 2013-06-30
NCT01831960 An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01831960 Completed Intrepid Therapeutics, Inc. 2013-11-30
NCT01830764 Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01830764 Completed Dermira, Inc. 2013-06-30
NCT01815450 BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT01815450 Completed Braintree Laboratories 2013-11-30
NCT01807455 An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine https://ClinicalTrials.gov/show/NCT01807455 Completed Q-Med AB 2014-12-31
NCT01796665 A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01796665 Completed Perrigo Company 2013-02-28
NCT01788384 Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris https://ClinicalTrials.gov/show/NCT01788384 Completed Watson Laboratories, Inc. 2012-12-31
NCT01773122 Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris https://ClinicalTrials.gov/show/NCT01773122 Completed Allergan 2013-05-05
NCT01769235 Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01769235 Completed Taro Pharmaceuticals USA 2013-09-30
NCT01755247 A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01755247 Completed Novan, Inc. 2012-11-30
NCT01742637 Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01742637 Completed Taro Pharmaceuticals USA 2014-02-28
NCT01706263 U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne https://ClinicalTrials.gov/show/NCT01706263 Completed GlaxoSmithKline 2009-11-20
NCT01706250 U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITYâ„¢ II to PROACTIVâ„¢ https://ClinicalTrials.gov/show/NCT01706250 Completed GlaxoSmithKline 2010-01-01
NCT01701024 Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne https://ClinicalTrials.gov/show/NCT01701024 Completed Bausch Health Americas, Inc. 2013-05-31
NCT01696513 Effect of Subcision and Suction on Acne Scars https://ClinicalTrials.gov/show/NCT01696513 Active, not recruiting Northwestern University 2020-12-31
NCT01694810 Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01694810 Completed Novan, Inc. 2012-11-30
NCT01694433 “Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy” https://ClinicalTrials.gov/show/NCT01694433 Completed University of California, Los Angeles 2014-01-09
NCT01689935 Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT) https://ClinicalTrials.gov/show/NCT01689935 Completed Massachusetts General Hospital 2013-09-30
NCT01688531 A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients https://ClinicalTrials.gov/show/NCT01688531 Completed Galderma R&D 2013-09-30
NCT01687556 EGCG Improves Acne by Modulating Molecular Targets https://ClinicalTrials.gov/show/NCT01687556 Completed Seoul National University Hospital 2006-06-30
NCT01682200 Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne https://ClinicalTrials.gov/show/NCT01682200 Completed Medivet Pty Ltd 2010-03-31
NCT01678482 Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment https://ClinicalTrials.gov/show/NCT01678482 Completed Home Skinovations Ltd. 2012-04-30
NCT01677221 Effects of Acleara Needle Insert on Acne https://ClinicalTrials.gov/show/NCT01677221 Completed Theravant Corporation 2013-01-31
NCT01631474 A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT01631474 Completed Intrepid Therapeutics, Inc. 2014-02-28
NCT01629797 Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne https://ClinicalTrials.gov/show/NCT01629797 Completed Northwestern University 2012-11-30
NCT01628549 Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT01628549 Completed Almirall, S.A. 2012-11-16
NCT01616654 Dose Range Study of CD5789 in Acne Vulgaris https://ClinicalTrials.gov/show/NCT01616654 Completed Galderma 2013-07-31
NCT01584674 A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne https://ClinicalTrials.gov/show/NCT01584674 Completed KLOX Technologies Inc. 2013-04-30
NCT01556698 Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT01556698 Completed Novan, Inc. 2011-12-31
NCT01527123 A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01527123 Completed GlaxoSmithKline 2012-06-01
NCT01522456 Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel https://ClinicalTrials.gov/show/NCT01522456 Completed Galderma Laboratories, L.P. 2012-05-31
NCT01504204 Effect of Samples on Acne Treatment With Epiduo® Gel https://ClinicalTrials.gov/show/NCT01504204 Completed Wake Forest University Health Sciences 2012-11-30
NCT01501799 A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduoâ„¢ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT01501799 Completed Actavis Mid-Atlantic LLC 2011-12-31
NCT01498874 Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT01498874 Completed XOMA (US) LLC 2013-04-30
NCT01494285 Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients https://ClinicalTrials.gov/show/NCT01494285 Completed M. Arkin 1999 Ltd. 2013-10-31
NCT01492647 A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01492647 Completed Janssen Pharmaceutical K.K. 2011-10-31
NCT01490736 Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne https://ClinicalTrials.gov/show/NCT01490736 Completed Dermira, Inc. 2013-03-31
NCT01474798 Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT01474798 Completed XBiotech, Inc. 2012-10-31
NCT01474590 Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne https://ClinicalTrials.gov/show/NCT01474590 Completed Galderma 2013-07-31
NCT01472900 2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne https://ClinicalTrials.gov/show/NCT01472900 Completed Chulalongkorn University 2012-04-30
NCT01466673 An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment https://ClinicalTrials.gov/show/NCT01466673 Completed Janssen-Cilag Ltd.,Thailand 2010-03-31
NCT01461655 Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01461655 Completed LEO Pharma 2012-04-30
NCT01446237 U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne https://ClinicalTrials.gov/show/NCT01446237 Completed GlaxoSmithKline 2011-12-01
NCT01445301 Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects https://ClinicalTrials.gov/show/NCT01445301 Completed GlaxoSmithKline 2012-08-02
NCT01428466 Japanese Phase 1 Study of GSK2585823 https://ClinicalTrials.gov/show/NCT01428466 Completed GlaxoSmithKline 2011-02-15
NCT01404130 A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory https://ClinicalTrials.gov/show/NCT01404130 Completed University of Aberdeen 2010-11-30
NCT01400932 Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects https://ClinicalTrials.gov/show/NCT01400932 Completed GlaxoSmithKline 2012-04-30
NCT01399970 Use of Mobile Teledermatology in the Care of Acne Patients https://ClinicalTrials.gov/show/NCT01399970 Completed Medical University of Graz 2012-12-31
NCT01387048 Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin https://ClinicalTrials.gov/show/NCT01387048 Completed University of Magdeburg 2012-08-31
NCT01362010 Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients https://ClinicalTrials.gov/show/NCT01362010 Completed Foamix Ltd. 2013-06-30
NCT01348321 Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne https://ClinicalTrials.gov/show/NCT01348321 Completed Ahvaz Jundishapur University of Medical Sciences 2009-10-31
NCT01347879 A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01347879 Completed Photocure 2012-04-30
NCT01326780 A Study of a New Drug Treatment for Acne https://ClinicalTrials.gov/show/NCT01326780 Completed Bausch Health Americas, Inc. 2012-03-31
NCT01321645 Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01321645 Completed Miglani, Anjali 2012-05-31
NCT01321632 Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01321632 Completed Miglani, Anjali 2012-06-30
NCT01320033 Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01320033 Completed Galderma 2012-01-03
NCT04433143 Evaluate the Efficacy and Safety of Intense Pulsed Light Filters Combined With Oral Medication in the Treatment of Acne https://ClinicalTrials.gov/show/NCT04433143 Enrolling by invitation Xijing Hospital 2021-05-06
NCT04321070 Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04321070 Completed Taro Pharmaceuticals USA 2019-12-14
NCT04300010 Blue Light Therapy of C. Acnes https://ClinicalTrials.gov/show/NCT04300010 Recruiting University of Wisconsin, Madison 2022-03-31
NCT04254601 Laser Therapy Versus Narrow Band Ultraviolet B for the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04254601 Completed Cairo University 2019-06-30
NCT04216160 Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo. https://ClinicalTrials.gov/show/NCT04216160 Active, not recruiting YUN NV 2019-11-28
NCT04214639 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04214639 Recruiting Bausch Health Americas, Inc. 2020-07-31
NCT04213638 Trial of Single Microneedle Radiofrequency for Moderate‐to‐Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT04213638 Recruiting Xiangya Hospital of Central South University 2020-11-30
NCT04206631 Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT04206631 Completed Indonesia University 2015-09-30
NCT04167982 Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT04167982 Recruiting Shanghai Dermatology Hospital 2022-11-30
NCT04163263 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT04163263 Recruiting Boston Pharmaceuticals 2020-07-31
NCT04156815 Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy https://ClinicalTrials.gov/show/NCT04156815 Completed Xijing Hospital 2018-10-05
NCT04106778 DMT310-003 Topical in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04106778 Recruiting Dermata Therapeutics 2020-06-30
NCT04134273 Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04134273 Completed Taro Pharmaceuticals USA 2019-09-17
NCT04118296 Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream https://ClinicalTrials.gov/show/NCT04118296 Completed Sukma Skin Treatment 2019-11-06
NCT04104685 A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. https://ClinicalTrials.gov/show/NCT04104685 Active, not recruiting Foamix Ltd. 2020-02-28
NCT04059523 MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 https://ClinicalTrials.gov/show/NCT04059523 Completed Sol-Gel Technologies, Ltd. 2020-02-06
NCT04057768 Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles https://ClinicalTrials.gov/show/NCT04057768 Active, not recruiting Venus Concept 2020-07-19
NCT04045119 Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin Hydration and Acne-prone Skin https://ClinicalTrials.gov/show/NCT04045119 Completed Avicanna Inc 2020-01-02
NCT04018885 A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris https://ClinicalTrials.gov/show/NCT04018885 Completed Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 2020-01-20
NCT04015375 Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04015375 Completed Torrent Pharmaceuticals Limited 2020-02-03
NCT04002024 Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne https://ClinicalTrials.gov/show/NCT04002024 Recruiting Mahidol University 2020-04-01
NCT03961607 Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Moderate or Severe Acne https://ClinicalTrials.gov/show/NCT03961607 Recruiting Shanghai Dermatology Hospital 2019-12-30
NCT03933033 Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars https://ClinicalTrials.gov/show/NCT03933033 Completed Aswan University Hospital 2018-08-31
NCT03915860 Subject Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris https://ClinicalTrials.gov/show/NCT03915860 Completed Galderma R&D 2019-12-23
NCT03901417 Comparison of 1550nm Fractional Laser Alone Versus in Combination With Microneedling for the Treatment of Acne Scars https://ClinicalTrials.gov/show/NCT03901417 Active, not recruiting Massachusetts General Hospital 2020-06-30
NCT03900676 Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT03900676 Active, not recruiting Vyome Therapeutics Inc. 2019-11-30
NCT03883269 Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients https://ClinicalTrials.gov/show/NCT03883269 Recruiting Centre for Human Drug Research, Netherlands 2019-06-30
NCT03878238 A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne https://ClinicalTrials.gov/show/NCT03878238 Completed Bionou Research, S.L. 2019-04-15
NCT03850925 Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars https://ClinicalTrials.gov/show/NCT03850925 Recruiting Dongtan Sacred Heart Hospital 2020-04-30
NCT03818555 Sebacia Postmarket Study of Real-World Use https://ClinicalTrials.gov/show/NCT03818555 Active, not recruiting Sebacia, Inc. 2020-06-30
NCT03761810 A Study of S6G5T 3 in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03761810 Completed Sol-Gel Technologies, Ltd. 2019-12-11
NCT03761784 A Study of S6G5T-3 in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03761784 Completed Sol-Gel Technologies, Ltd. 2019-12-17
NCT03743038 A Study Comparing Two Topicals in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03743038 Completed Foamix Ltd. 2019-02-11
NCT03717506 Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT03717506 Active, not recruiting Gage Development Company, LLC 2020-06-30
NCT03709654 A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne https://ClinicalTrials.gov/show/NCT03709654 Active, not recruiting Naked Biome, Inc. 2019-09-30
NCT03653403 Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel https://ClinicalTrials.gov/show/NCT03653403 Completed Bausch Health Americas, Inc. 2019-06-19
NCT03650361 Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT03650361 Completed Aleor Dermaceuticals Limited 2019-02-16
NCT03626298 Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia https://ClinicalTrials.gov/show/NCT03626298 Completed Rumah Sakit Pusat Angkatan Darat Gatot Soebroto 2016-12-31
NCT03615768 A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03615768 Completed Lee’s Pharmaceutical Limited 2020-02-13
NCT03599193 A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT03599193 Completed Dr. Reddy’s Laboratories Limited 2018-04-30
NCT03585140 Low Glycemic Index and Load Diet for the Treatment of Acne https://ClinicalTrials.gov/show/NCT03585140 Completed Centro Dermatológico Dr. Ladislao de la Pascua 2016-05-01
NCT03573518 Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT03573518 Completed Botanix Pharmaceuticals 2019-08-16
NCT03573115 Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery https://ClinicalTrials.gov/show/NCT03573115 Active, not recruiting Bispebjerg Hospital 2018-07-18
NCT03536637 DMT310-001 Topical in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03536637 Completed Dermata Therapeutics 2018-12-30
NCT03522922 Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring https://ClinicalTrials.gov/show/NCT03522922 Completed Sohag University 2018-02-01
NCT03522441 Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03522441 Completed Akorn, Inc. 2019-04-22
NCT03497897 Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne https://ClinicalTrials.gov/show/NCT03497897 Recruiting Novartis 2020-11-16
NCT03457636 The Use of Oracea and Epiduo Forte in Severe Acne Patients https://ClinicalTrials.gov/show/NCT03457636 Completed Derm Research, PLLC 2018-11-01
NCT03450369 A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne https://ClinicalTrials.gov/show/NCT03450369 Completed Naked Biome, Inc. 2018-06-18
NCT03433378 To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03433378 Completed Taro Pharmaceuticals USA 2018-01-26
NCT03427554 To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03427554 Completed Taro Pharmaceuticals USA 2018-01-26
NCT01257906 Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo https://ClinicalTrials.gov/show/NCT01257906 Completed Actavis Mid-Atlantic LLC 2010-10-31
NCT01245946 Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01245946 Completed Pontificia Universidad Catolica de Chile 2011-05-31
NCT01241331 BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT01241331 Completed Braintree Laboratories 2011-04-30
NCT01237821 Comparing OTC Acne Treatment to Prescription Regimen https://ClinicalTrials.gov/show/NCT01237821 Completed Milton S. Hershey Medical Center 2011-08-31
NCT01231334 A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne https://ClinicalTrials.gov/show/NCT01231334 Completed Allergan 2011-06-30
NCT01221922 Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI https://ClinicalTrials.gov/show/NCT01221922 Completed Cynosure, Inc. 2012-01-31
NCT01213199 Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars https://ClinicalTrials.gov/show/NCT01213199 Completed Galderma 2012-04-30
NCT01209949 Assessment of Subjects’ Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01209949 Completed Galderma Laboratories, L.P. 2011-01-31
NCT01206348 Combination Treatment for Moderate to Severe Acne https://ClinicalTrials.gov/show/NCT01206348 Completed Medicis Global Service Corporation 2011-07-31
NCT01194375 A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01194375 Completed Dow Pharmaceutical Sciences 2011-12-31
NCT01188538 Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel https://ClinicalTrials.gov/show/NCT01188538 Completed Galderma 2010-08-31
NCT01182636 Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01182636 Completed Teva Pharmaceuticals USA 2008-04-30
NCT01180543 Acne Treatment With Active Oplon’s Patches https://ClinicalTrials.gov/show/NCT01180543 Completed Oplon-Pure Science Ltd. 2010-10-31
NCT01179633 Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid https://ClinicalTrials.gov/show/NCT01179633 Completed Oplon-Pure Science Ltd. 2010-06-30
NCT01176955 A Novel Method to Improve Acne Outcomes https://ClinicalTrials.gov/show/NCT01176955 Completed Wake Forest University Health Sciences 2010-08-31
NCT01162837 Safety & Effectiveness of the BEAM Device in Mild-to-moderate Acne https://ClinicalTrials.gov/show/NCT01162837 Completed Oregon Aesthetic Technologies 2010-09-30
NCT01160757 A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions https://ClinicalTrials.gov/show/NCT01160757 Completed Arizona State University 2009-07-31
NCT01149330 Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01149330 Completed Galderma Brasil Ltda. 2011-03-31
NCT01138735 Epiduo Pediatric Acne Study https://ClinicalTrials.gov/show/NCT01138735 Completed Galderma 2011-08-31
NCT01138514 Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels https://ClinicalTrials.gov/show/NCT01138514 Completed Perrigo Company 2010-10-31
NCT01132443 W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne https://ClinicalTrials.gov/show/NCT01132443 Completed GlaxoSmithKline 2010-06-12
NCT01119651 A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers. https://ClinicalTrials.gov/show/NCT01119651 Completed GlaxoSmithKline 2010-06-26
NCT01115322 A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers https://ClinicalTrials.gov/show/NCT01115322 Completed GlaxoSmithKline 2010-04-10
NCT01114841 A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers https://ClinicalTrials.gov/show/NCT01114841 Completed GlaxoSmithKline 2010-06-26
NCT01112787 A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01112787 Completed GlaxoSmithKline 2010-04-26
NCT01106807 Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne https://ClinicalTrials.gov/show/NCT01106807 Completed Galderma 2010-09-30
NCT01095640 Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel https://ClinicalTrials.gov/show/NCT01095640 Completed Actavis Inc. 2009-12-31
NCT01052246 Pulsed Dye Laser Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01052246 Completed Laserklinik Karlsruhe 2009-06-30
NCT01050465 MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use https://ClinicalTrials.gov/show/NCT01050465 Completed University of Missouri-Columbia 2010-10-31
NCT01047189 Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT01047189 Completed Wake Forest University Health Sciences 2009-10-31
NCT01044264 Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations https://ClinicalTrials.gov/show/NCT01044264 Completed Perrigo Company 2008-09-30
NCT01040390 Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01040390 Completed Miglani, Anjali 2011-12-31
NCT01038869 Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) https://ClinicalTrials.gov/show/NCT01038869 Completed Derm Research, PLLC 2010-04-30
NCT01019603 A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01019603 Completed GlaxoSmithKline 2009-12-20
NCT01017146 A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 https://ClinicalTrials.gov/show/NCT01017146 Completed GlaxoSmithKline 2010-11-30
NCT01017120 A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne https://ClinicalTrials.gov/show/NCT01017120 Completed GlaxoSmithKline 2010-11-01
NCT01016977 A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT01016977 Completed GlaxoSmithKline 2010-04-30
NCT01015638 Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications https://ClinicalTrials.gov/show/NCT01015638 Completed GlaxoSmithKline 2009-09-30
NCT01014689 Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris https://ClinicalTrials.gov/show/NCT01014689 Completed Galderma 2010-04-30
NCT00991198 The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage https://ClinicalTrials.gov/show/NCT00991198 Completed Aria Aesthetics Inc. 2010-01-31
NCT00975143 Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne https://ClinicalTrials.gov/show/NCT00975143 Completed Cipher Pharmaceuticals Inc. 2011-05-31
NCT00974870 A Pilot Study Testing the Efficacy of a Needling Device for the Treatment of Acne Scars https://ClinicalTrials.gov/show/NCT00974870 Completed Northwestern University 2010-07-31
NCT00964366 Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications https://ClinicalTrials.gov/show/NCT00964366 Completed GlaxoSmithKline 2009-08-31
NCT00964223 A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne https://ClinicalTrials.gov/show/NCT00964223 Completed GlaxoSmithKline 2009-11-30
NCT00952523 Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face https://ClinicalTrials.gov/show/NCT00952523 Completed Bausch Health Americas, Inc. 2009-10-31
NCT00933543 Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT) https://ClinicalTrials.gov/show/NCT00933543 Completed Photocure 2010-03-31
NCT00926367 Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications https://ClinicalTrials.gov/show/NCT00926367 Completed GlaxoSmithKline 2009-06-30
NCT00919191 Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face https://ClinicalTrials.gov/show/NCT00919191 Completed Bausch Health Americas, Inc. 2009-05-31
NCT00913185 Comparison Study of Topical Acne Regimens https://ClinicalTrials.gov/show/NCT00913185 Completed MedDerm Associates 2006-12-31
NCT00907335 A Study of Acne Treatment in Children Ages 9 to 11 https://ClinicalTrials.gov/show/NCT00907335 Completed Bausch Health Americas, Inc. 2009-12-31
NCT00907257 A Study of Different Use Regimens Using Two Acne Treatments https://ClinicalTrials.gov/show/NCT00907257 Completed Bausch Health Americas, Inc. 2009-09-30
NCT00907101 Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes https://ClinicalTrials.gov/show/NCT00907101 Completed Galderma Laboratories, L.P. 2009-07-31
NCT00900939 Plant-based Dietary Intervention for Treatment of Acne https://ClinicalTrials.gov/show/NCT00900939 Completed Physicians Committee for Responsible Medicine 2009-11-30
NCT00891982 A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash https://ClinicalTrials.gov/show/NCT00891982 Completed GlaxoSmithKline 2009-06-01
NCT00887484 A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne https://ClinicalTrials.gov/show/NCT00887484 Completed GlaxoSmithKline 2009-06-30
NCT00883233 Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris https://ClinicalTrials.gov/show/NCT00883233 Completed Galderma 2009-09-30
NCT00848744 Comparison of Two Salicylic Acid Formulations https://ClinicalTrials.gov/show/NCT00848744 Completed Northwestern University 2008-08-31
NCT00838812 Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate https://ClinicalTrials.gov/show/NCT00838812 Completed Igefarma Laboratorios S.A. 2010-01-31
NCT03752242 Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. https://ClinicalTrials.gov/show/NCT03752242 Recruiting BioMimetix JV, LLC 2022-09-30
NCT03664752 Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03664752 Recruiting Bausch Health Americas, Inc. 2019-12-31
NCT03664739 Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03664739 Completed Bausch Health Americas, Inc. 2020-03-23
NCT03524040 Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT03524040 Completed Bispebjerg Hospital 2017-12-31
NCT03271021 A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT03271021 Completed Foamix Ltd. 2018-09-04
NCT00834210 Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT00834210 Completed Allergan 2009-09-30
NCT00833183 Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne https://ClinicalTrials.gov/show/NCT00833183 Completed Photocure 2008-07-31
NCT03563365 The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol https://ClinicalTrials.gov/show/NCT03563365 Recruiting Yardley Dermatology Associates 2020-01-04
NCT02216864 Effect of Multiple Subcisions on Rolling Acne Scars https://ClinicalTrials.gov/show/NCT02216864 Active, not recruiting Northwestern University 2020-12-31
NCT00841776 Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne https://ClinicalTrials.gov/show/NCT00841776 Completed GlaxoSmithKline 2008-11-30
NCT01974323 Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01974323 Completed Almirall, S.A. 2014-10-31
NCT01910064 A Long Term Study of GK530G in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01910064 Completed Galderma R&D 2014-08-31
NCT01769664 A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT01769664 Completed Taro Pharmaceuticals USA 2013-06-30
NCT04214652 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT04214652 Recruiting Bausch Health Americas, Inc. 2020-07-31
NCT03307577 A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT03307577 Completed Therapeutics, Inc. 2018-05-31
NCT03292640 A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks https://ClinicalTrials.gov/show/NCT03292640 Completed Dr. Reddy’s Laboratories Limited 2018-05-14
NCT03132194 Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT03132194 Completed Taro Pharmaceuticals USA 2017-01-16
NCT03071549 Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne https://ClinicalTrials.gov/show/NCT03071549 Completed Cairo University 2016-08-31
NCT02581072 A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 https://ClinicalTrials.gov/show/NCT02581072 Completed Novan, Inc. 2015-12-31
NCT02413346 A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT02413346 Completed Almirall, S.A. 2016-08-26
NCT03681470 Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color https://ClinicalTrials.gov/show/NCT03681470 Recruiting Icahn School of Medicine at Mount Sinai 2020-12-31
NCT02556788 Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris https://ClinicalTrials.gov/show/NCT02556788 Completed Galderma R&D 2017-02-07
NCT01657110 Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne https://ClinicalTrials.gov/show/NCT01657110 Completed The University of Western Australia 2014-12-31
NCT01160848 Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients https://ClinicalTrials.gov/show/NCT01160848 Completed Photocure 2011-01-31
NCT00807014 Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne https://ClinicalTrials.gov/show/NCT00807014 Completed GlaxoSmithKline 2008-08-31
NCT00787943 Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT00787943 Completed Northwestern University 2009-01-31
NCT00776919 Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne https://ClinicalTrials.gov/show/NCT00776919 Completed GlaxoSmithKline 2009-09-30
NCT00767104 Efficacy of Silk - Like Bedding Fabric Pillow Case in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT00767104 Completed Wake Forest University Health Sciences 2009-03-31
NCT00757523 Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT00757523 Completed GlaxoSmithKline 2009-04-24
NCT00752635 Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT00752635 Completed Johnson & Johnson Taiwan Ltd NA
NCT00748462 Fractional CO2 Treatment of Acne Scars in Asians https://ClinicalTrials.gov/show/NCT00748462 Completed Mahidol University 2008-12-31
NCT00725439 An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne https://ClinicalTrials.gov/show/NCT00725439 Completed GlaxoSmithKline 2005-07-31
NCT00722761 Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne https://ClinicalTrials.gov/show/NCT00722761 Completed Massachusetts General Hospital 2012-04-30
NCT00714714 Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face. https://ClinicalTrials.gov/show/NCT00714714 Completed Bausch Health Americas, Inc. 2008-02-29
NCT00714454 5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT00714454 Completed University of Miami NA
NCT00713609 Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne https://ClinicalTrials.gov/show/NCT00713609 Completed GlaxoSmithKline 2009-03-31
NCT00706433 Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne https://ClinicalTrials.gov/show/NCT00706433 Completed DUSA Pharmaceuticals, Inc. 2008-07-31
NCT00696449 Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT00696449 Completed Wake Forest University Health Sciences 2007-05-31
NCT00689117 A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel https://ClinicalTrials.gov/show/NCT00689117 Completed GlaxoSmithKline 2009-04-30
NCT00688064 Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris https://ClinicalTrials.gov/show/NCT00688064 Completed Galderma 2009-02-28
NCT00687908 Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance https://ClinicalTrials.gov/show/NCT00687908 Completed Galderma 2009-07-31
NCT00673933 Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00673933 Completed Photocure 2008-12-31
NCT00671749 Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00671749 Completed Galderma Laboratories, L.P. 2008-08-31
NCT00666900 A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00666900 Completed Dow Pharmaceutical Sciences 2009-03-31
NCT00664248 A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00664248 Completed Dow Pharmaceutical Sciences 2007-08-31
NCT00663286 A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00663286 Completed Dow Pharmaceutical Sciences 2007-08-31
NCT00660985 Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% https://ClinicalTrials.gov/show/NCT00660985 Completed Galderma 2008-08-31
NCT00656981 Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne https://ClinicalTrials.gov/show/NCT00656981 Completed Bayer NA
NCT00651469 Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne. https://ClinicalTrials.gov/show/NCT00651469 Completed Bayer NA
NCT00635609 Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate https://ClinicalTrials.gov/show/NCT00635609 Completed Warner Chilcott 2008-09-30
NCT00624676 Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT00624676 Completed Cosmetique Active International 2006-08-31
NCT00612573 Treatment of Moderate to Severe Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT00612573 Completed Warner Chilcott 2008-11-30
NCT00599521 Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% https://ClinicalTrials.gov/show/NCT00599521 Completed Galderma 2008-11-30
NCT00598832 Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% https://ClinicalTrials.gov/show/NCT00598832 Completed Galderma 2008-10-31
NCT00594425 Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne https://ClinicalTrials.gov/show/NCT00594425 Completed Photocure 2008-07-31
NCT00558831 Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT00558831 Completed Northwestern University 2008-01-31
NCT00525499 A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris https://ClinicalTrials.gov/show/NCT00525499 Completed AndroScience Corp 2008-04-30
NCT00483145 Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea https://ClinicalTrials.gov/show/NCT00483145 Completed Bispebjerg Hospital NA
NCT00469755 Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne https://ClinicalTrials.gov/show/NCT00469755 Completed Galderma Laboratories, L.P. 2006-09-30
NCT00446043 A Long-Term Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00446043 Completed Galderma NA
NCT00441415 Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris https://ClinicalTrials.gov/show/NCT00441415 Completed Galderma 2007-10-31
NCT00437151 Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1% https://ClinicalTrials.gov/show/NCT00437151 Completed Galderma Laboratories, L.P. 2007-06-30
NCT00422240 Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00422240 Completed Galderma NA
NCT00421993 A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris https://ClinicalTrials.gov/show/NCT00421993 Completed Galderma 2007-10-31
NCT00417456 The Development and Evaluation of an “E-Visit” Program for the Management of Acne https://ClinicalTrials.gov/show/NCT00417456 Completed Massachusetts General Hospital 2007-12-31
NCT00377000 A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels. https://ClinicalTrials.gov/show/NCT00377000 Completed Sanofi NA
NCT00361322 Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris https://ClinicalTrials.gov/show/NCT00361322 Completed Hadassah Medical Organization NA
NCT00355485 Microdermabrasion for Acne https://ClinicalTrials.gov/show/NCT00355485 Completed University of Michigan 2007-07-31
NCT00280657 Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa https://ClinicalTrials.gov/show/NCT00280657 Completed Bayer 2005-05-31
NCT00243542 Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency https://ClinicalTrials.gov/show/NCT00243542 Completed Allergan 2006-10-31
NCT00219570 Dalacin-T Gel Post Approval Study https://ClinicalTrials.gov/show/NCT00219570 Completed Pfizer NA
NCT00211523 Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne https://ClinicalTrials.gov/show/NCT00211523 Completed BioWest Therapeutics Inc NA
NCT00211497 Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne https://ClinicalTrials.gov/show/NCT00211497 Completed BioWest Therapeutics Inc NA
NCT00206895 Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study https://ClinicalTrials.gov/show/NCT00206895 Completed Bispebjerg Hospital NA
NCT00160394 Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris https://ClinicalTrials.gov/show/NCT00160394 Completed GlaxoSmithKline 2005-08-31
NCT00151541 A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% https://ClinicalTrials.gov/show/NCT00151541 Completed Allergan 2005-07-31
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris https://ClinicalTrials.gov/show/NCT00145106 Completed KGL, Inc. NA
NCT00113425 Non-cutting Laser Therapy in the Treatment of Acne https://ClinicalTrials.gov/show/NCT00113425 Completed University of Michigan 2008-11-30
NCT00110643 Infrared Non-Cutting Laser Therapy for Acne https://ClinicalTrials.gov/show/NCT00110643 Completed University of Michigan NA
NCT00837213 Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne https://ClinicalTrials.gov/show/NCT00837213 Completed GlaxoSmithKline 2008-08-31
NCT00818519 GA YAZ ACNE in China Phase III https://ClinicalTrials.gov/show/NCT00818519 Completed Bayer 2010-05-31
NCT00795327 Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring https://ClinicalTrials.gov/show/NCT00795327 Completed Bausch Health Americas, Inc. 2009-09-30
NCT00031096 Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne https://ClinicalTrials.gov/show/NCT00031096 Completed LEO Pharma 2002-07-31
NCT00658112 Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne https://ClinicalTrials.gov/show/NCT00658112 Completed Wake Forest University Health Sciences 2008-05-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03192163 Cultural Differences in Treatment Preferences and Perceptions of Acne https://ClinicalTrials.gov/show/NCT03192163 Completed Northwestern University 2018-02-28
NCT03039634 Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA https://ClinicalTrials.gov/show/NCT03039634 Completed Sienna Labs 2018-05-31
NCT02410031 Risk Minimisation Study for Diane-35 and Its Generics https://ClinicalTrials.gov/show/NCT02410031 Completed Bayer 2016-03-04
NCT02349399 Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases https://ClinicalTrials.gov/show/NCT02349399 Completed Bayer 2016-03-01
NCT02338544 Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne https://ClinicalTrials.gov/show/NCT02338544 Completed Galderma Laboratorium GmbH 2015-09-30
NCT02270411 Inflammatory Cells From Various Pathologies https://ClinicalTrials.gov/show/NCT02270411 Recruiting Innovaderm Research Inc. 2021-12-31
NCT02180425 The Lipid Profile of the Skin Surface in Acne https://ClinicalTrials.gov/show/NCT02180425 Completed University of California, Davis 2015-05-31
NCT01931774 Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01931774 Completed Bezmialem Vakif University 2013-07-31
NCT01929057 Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris https://ClinicalTrials.gov/show/NCT01929057 Completed University of California, San Diego 2014-06-30
NCT01835210 Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life https://ClinicalTrials.gov/show/NCT01835210 Completed Ann & Robert H Lurie Children’s Hospital of Chicago 2014-06-30
NCT01727440 Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment https://ClinicalTrials.gov/show/NCT01727440 Completed Duke University 2015-08-31
NCT01618773 Long-term Study of Epiduo in Patients With Moderate to Severe Acne https://ClinicalTrials.gov/show/NCT01618773 Completed Galderma Laboratorium GmbH 2013-09-30
NCT04367584 Comparison of Malassezia Spp Proportions in Inflammatory and Non Inflammatory Facial Acne Vulgaris Lesions https://ClinicalTrials.gov/show/NCT04367584 Completed Indonesia University 2018-11-30
NCT04301063 Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year https://ClinicalTrials.gov/show/NCT04301063 Active, not recruiting Pierre Fabre Dermo Cosmetique 2020-05-31
NCT04214483 A Pilot Study to Explore the Role of Gut Flora in Acne https://ClinicalTrials.gov/show/NCT04214483 Recruiting ProgenaBiome 2023-03-31
NCT04056598 Acne Vulgaris Related Microbiology and Serology https://ClinicalTrials.gov/show/NCT04056598 Active, not recruiting Origimm Biotechnology GmbH 2019-09-30
NCT03921476 Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function https://ClinicalTrials.gov/show/NCT03921476 Recruiting Northwestern University 2020-06-30
NCT03411733 Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris https://ClinicalTrials.gov/show/NCT03411733 Completed Sohag University 2018-02-01
NCT01220102 Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne https://ClinicalTrials.gov/show/NCT01220102 Completed Galderma Laboratorium GmbH 2010-11-30
NCT00306371 Comparison of Stacked-Pulses Vs. Double-Pass Treatments of Facial Acne With a 1450 Nm Laser https://ClinicalTrials.gov/show/NCT00306371 Completed Skincare Physicians of Chestnut Hill NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01948570 Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment https://ClinicalTrials.gov/show/NCT01948570 Completed Derming SRL 2013-06-30